Nav: Home

More women in US receive 3D mammography but disparities remain

June 24, 2019

New Haven, Conn. -- Use of 3-D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale researchers in a new study. But adoption of the technology varies widely, reflecting emerging disparities in care, they said.

The study was published in the journal JAMA Internal Medicine.

Three-D mammography is also commonly called digital breast tomosynthesis, or DBT. The technology combines low-dose X-rays with software that creates a 3-D image of the breast. Compared to 2-D mammography, DBT may make it easier for radiologists to detect an abnormality. Yet DBT has not been widely endorsed for routine breast cancer screening. Organizations like the U.S. Preventive Services Task Force and the American Cancer Society, which provide guidance to clinicians about cancer screening, have not made recommendations for or against the routine use of DBT.

To assess the extent of DBT use nationwide, the Yale team examined claims data from private health insurance plans. Their investigation included more than 9 million screening exams performed over three years. They also compared DBT use with privately insured versus Medicare-insured patients.

The researchers found that DBT use rose substantially, from 12.9% to 43.2% of screening exams between 2015 and 2017. The increase was consistent among women who were privately insured and women with Medicare.

"DBT has become very popular overall, although uptake has been uneven. In some areas of the country, it is rarely used while in others, it is the predominant mode of screening," said corresponding author Ilana Richman, M.D., assistant professor in the Section of General Internal Medicine at the Yale School of Medicine.

Richman and her co-authors also observed that adoption of DBT varied greatly by region and demographics. Use of the technology grew more quickly in the Northeast and Northwest but more slowly in the Southeast. DBT was more rapidly adopted in areas with higher incomes, greater education, and larger white populations, they said.

While there is evidence that DBT may boost cancer detection rates and reduce false-positive results, more research is needed to determine the true impact of the technology on breast cancer mortality, said the researchers.

"Although there is a lot of interest in this new technology, we don't know much about how it will affect the long-term health of women," Richman noted. "There are ongoing studies designed to answer these questions, and we hope to have clearer answers in the next few years."

The authors predict that, given these findings, DBT will replace 2-D mammography as the standard of care. "These findings highlight how quickly changes in medical practice -- the rate that doctors adopt these new tests -- can eclipse our ability to evaluate whether they are helping patients to live longer and healthier lives," said senior author and professor of medicine Cary Gross, M.D.
-end-
The other Yale authors are Jessica Hoag, Xiao Xu, Howard Forman, Regina Hooley, and Susan Busch.

The Yale researchers accessed the deidentified data through Yale University's participation in the Blue Cross Blue Shield Alliance for Health Research (BCBS Alliance), which engages leading U.S. healthcare researchers in collaborative efforts to improve the health of Americans. Funding for this work was provided by a National Institutes of Health/National Center for Advancing Translational Sciences grant (KL2 TR001862) and by the American Cancer Society. Richman received grants from NIH/NCATS and fees from the Centers for Medicare and Medicaid. Additional disclosures are reported in JAMA Internal Medicine.

Citation: JAMA Internal Medicine

Yale University

Related Mammography Articles:

Tomosynthesis outperforms digital mammography in five-year study
A new study has found that the advantages of digital breast tomosynthesis (DBT) over digital mammography (DM), including increased cancer detection and fewer false positive findings, are maintained over multiple years and rounds of screening.
More women in US receive 3D mammography but disparities remain
Use of 3D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale researchers in a new study.
Managing architectural distortion on mammography based on MR enhancement
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US) correlate or magnetic resonance imaging (MRI) enhancement suggests follow-up rather than biopsy may be safely performed, according to a study to be presented at the ARRS 2019 Annual Meeting, set for May 5-10 in Honolulu, Hawaii.
Older women benefit significantly when screened with 3D mammography
Mammography remains an effective method for breast cancer screening in women ages 65 and older, with the addition of a 3D technique called tomosynthesis improving screening performances even more, according to a new study.
3D mammography significantly reduces breast biopsy rates
The use of digital breast tomosynthesis, also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study.
Digital mammography increases breast cancer detection
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study.
New study supports mammography screening at 30 for some women
A new, large-scale study of more than 5 million mammograms found that annual mammography screening beginning at age 30 may benefit women with at least one of three specific risk factors: dense breasts, a personal history of breast cancer or a family history of breast cancer.
Women benefit from mammography screening beyond age 75
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of breast cancer found in this age group, according to a new study.
3D mammography detected 34 percent more breast cancers in screening
After screening 15 000 women over a period of five years, a major clinical study in Sweden has shown that 3D mammography, or breast tomosynthesis, detects over 30 percent more cancers compared to traditional mammography - with a majority of the detected tumors proving to be invasive cancers.
Women more likely to use other preventive health services after mammography
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to undergo other preventive health services like screening for cervical cancer and osteoporosis, according to a major new study.
More Mammography News and Mammography Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.